Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
In Vivo (Athens, Greece)|December 29, 2015
CpG-Oligodeoxynucleotides in Chronic Rhinosinusitis Cell CultureRichard Birk, Christoph Aderhold, Karl Hörmann, et al.Laryngo- Rhino- Otologie|January 5, 2023
[The potential of complementary music interventions in patients with head and neck cancer]Daniel Haeussler, Christopher Mayer, Angela Schell, et al.Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|July 9, 2026
Awareness of Head and Neck Cancer, its Risk Factors, and of Human Papillomavirus-A Survey StudyTheresa Obermueller, Sarah Volpe, Denitze Lara Escobar, et al.Anticancer Research|May 29, 2017
Impact of Small Molecules on β-Catenin and E-Cadherin Expression in HPV16-positive and -negative Squamous Cell CarcinomasBenedikt Kramer, Clemens Hock, Johannes David Schultz, et al.Anticancer Research|July 26, 2024
Influence of Tyrosine Kinase Inhibitors and Everolimus on TGFβ1 and TGF-β Receptor 2 in Squamous Cell Carcinoma CellsLena Huber, Manuel Thomas Knüttel, Benedikt Kramer, et al.Head & Neck|October 10, 2017
Heated air humidification versus cold air nebulization in newly tracheostomized patientsRichard Birk, Alexander Händel, Angela Wenzel, et al.Der Anaesthesist|August 27, 2021
[Professional teamwork and communication in the operating room-A narrative review]Anne Lammert, Markus Alb, Lena Huber, et al.Nutrition and Cancer|October 2, 2018
Long-Term Quality of Life and Nutritional Status of Patients with Head and Neck CancerBenedikt Kramer, Angela Wenzel, Maja Boerger, et al.Anticancer Research|September 29, 2020
FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and EverolimusLena Huber, Richard Birk, Manuel Knuettel, et al.Anticancer Research|September 6, 2017
Communicate or Die - A Model for HPV+ and HPV- CSCs and Their Interactions with SDF-1αFrederic Jungbauer, Christoph Aderhold, Richard Birk, et al.Pageof 4